107 related articles for article (PubMed ID: 2296888)
1. Value of a revised procainamide test in the Wolff-Parkinson-White syndrome.
Boahene KA; Klein GJ; Sharma AD; Yee R; Fujimura O
Am J Cardiol; 1990 Jan; 65(3):195-200. PubMed ID: 2296888
[TBL] [Abstract][Full Text] [Related]
2. Procainamide infusion test: inability to identify patients with Wolff-Parkinson-White syndrome who are potentially at risk of sudden death.
Fananapazir L; Packer DL; German LD; Greer GS; Gallagher JJ; Pressley JC; Prystowsky EN
Circulation; 1988 Jun; 77(6):1291-6. PubMed ID: 3370769
[TBL] [Abstract][Full Text] [Related]
3. Linking: a mechanism of intermittent preexcitation in the Wolff-Parkinson-White syndrome.
Middlekauff HR; Stevenson WG; Klitzner TS
Pacing Clin Electrophysiol; 1990 Dec; 13(12 Pt 1):1629-36. PubMed ID: 1704516
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of noninvasive tests for identifying patients with preexcitation syndrome at risk of rapid ventricular response.
Critelli G; Gallagher JJ; Perticone F; Coltorti F; Monda V; Condorelli M
Am Heart J; 1984 Oct; 108(4 Pt 1):905-9. PubMed ID: 6486001
[TBL] [Abstract][Full Text] [Related]
5. Use of procainamide in patients with the Wolff-Parkinson-White syndrome to disclose a short refractory period of the accessory pathway.
Wellens HJ; Braat S; Brugada P; Gorgels AP; Bär FW
Am J Cardiol; 1982 Nov; 50(5):1087-9. PubMed ID: 7137035
[TBL] [Abstract][Full Text] [Related]
6. Value of the ajmaline-procainamide test to predict the effect of long-term oral amiodarone on the anterograde effective refractory period of the accessory pathway in the Wolff-Parkinson-White syndrome.
Brugada P; Dassen WR; Braat S; Gorgels AP; Wellens HJ
Am J Cardiol; 1983 Jul; 52(1):70-2. PubMed ID: 6858931
[TBL] [Abstract][Full Text] [Related]
7. Development of rapid preexcited ventricular response to atrial fibrillation in a patient with intermittent preexcitation.
Gemma LW; Steinberg LA; Prystowsky EN; Padanilam BJ
J Cardiovasc Electrophysiol; 2013 Mar; 24(3):347-50. PubMed ID: 22817823
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal electrophysiologic assessment of asymptomatic patients with the Wolff-Parkinson-White electrocardiographic pattern.
Klein GJ; Yee R; Sharma AD
N Engl J Med; 1989 May; 320(19):1229-33. PubMed ID: 2710202
[TBL] [Abstract][Full Text] [Related]
9. Stress and pharmacologic tests as methods to identify patients with Wolff-Parkinson-White syndrome at risk of sudden death.
Gaita F; Giustetto C; Riccardi R; Mangiardi L; Brusca A
Am J Cardiol; 1989 Sep; 64(8):487-90. PubMed ID: 2773792
[TBL] [Abstract][Full Text] [Related]
10. Loss of ventricular preexcitation during noninvasive testing does not exclude high-risk accessory pathways: A multicenter study of WPW in children.
Escudero CA; Ceresnak SR; Collins KK; Pass RH; Aziz PF; Blaufox AD; Ortega MC; Cannon BC; Cohen MI; Dechert BE; Dubin AM; Motonaga KS; Epstein MR; Erickson CC; Fishberger SB; Gates GJ; Capone CA; Nappo L; Kertesz NJ; Kim JJ; Valdes SO; Kubuš P; Law IH; Maldonado J; Moore JP; Perry JC; Sanatani S; Seslar SP; Shetty I; Zimmerman FJ; Skinner JR; Marcondes L; Stephenson EA; Asakai H; Tanel RE; Uzun O; Etheridge SP; Janson CM
Heart Rhythm; 2020 Oct; 17(10):1729-1737. PubMed ID: 32497761
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity and specificity of invasive and noninvasive testing for risk of sudden death in Wolff-Parkinson-White syndrome.
Sharma AD; Yee R; Guiraudon G; Klein GJ
J Am Coll Cardiol; 1987 Aug; 10(2):373-81. PubMed ID: 3598007
[TBL] [Abstract][Full Text] [Related]
12. [Influence of exercise on the permeability of accessory pathways and supraventricular arrhythmia in Wolff-Parkinson-White syndrome].
Mabo P; Kermarrec A; Gras D; Paillard F; Bédossa M; Daubert C
Arch Mal Coeur Vaiss; 1992 Oct; 85(10):1443-8. PubMed ID: 1297293
[TBL] [Abstract][Full Text] [Related]
13. [Electrophysiological properties of atrial fibrillation with WPW syndrome and the role of procainamide in conversion].
Li P
Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Apr; 19(2):65-6, 123. PubMed ID: 1879311
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of isoproterenol during atrial fibrillation in evaluation of asymptomatic Wolff-Parkinson-White pattern.
Szabo TS; Klein GJ; Sharma AD; Yee R; Milstein S
Am J Cardiol; 1989 Jan; 63(3):187-92. PubMed ID: 2909998
[TBL] [Abstract][Full Text] [Related]
15. Intermittent versus Persistent Wolff-Parkinson-White Syndrome in Children: Electrophysiologic Properties and Clinical Outcomes.
Kiger ME; McCanta AC; Tong S; Schaffer M; Runciman M; Collins KK
Pacing Clin Electrophysiol; 2016 Jan; 39(1):14-20. PubMed ID: 26256551
[TBL] [Abstract][Full Text] [Related]
16. Intermittent preexcitation in the Wolff-Parkinson-White syndrome.
Klein GJ; Gulamhusein SS
Am J Cardiol; 1983 Aug; 52(3):292-6. PubMed ID: 6869275
[TBL] [Abstract][Full Text] [Related]
17. Clinical usefulness of the 12-lead electrocardiogram in the Wolff-Parkinson-White syndrome.
Rinne C; Klein GJ; Sharma AD; Yee R
Cardiol Clin; 1987 Aug; 5(3):499-509. PubMed ID: 3319168
[TBL] [Abstract][Full Text] [Related]
18. Termination of acute atrial fibrillation in the Wolff-Parkinson-White syndrome by procainamide and propafenone: importance of atrial fibrillatory cycle length.
Boahene KA; Klein GJ; Yee R; Sharma AD; Fujimura O
J Am Coll Cardiol; 1990 Nov; 16(6):1408-14. PubMed ID: 2229793
[TBL] [Abstract][Full Text] [Related]
19. Ventricular fibrillation in the Wolff-Parkinson-White syndrome.
Klein GJ; Bashore TM; Sellers TD; Pritchett EL; Smith WM; Gallagher JJ
N Engl J Med; 1979 Nov; 301(20):1080-5. PubMed ID: 492252
[TBL] [Abstract][Full Text] [Related]
20. Effects of magnesium and potassium on Wolff-Parkinson-White syndrome.
Sideris AM; Galiatsu E; Filippatos GS; Kappos K; Anthopoulos LP
J Electrocardiol; 1996 Jan; 29(1):11-5. PubMed ID: 8808520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
